Jones R, Lydeard S. Dyspepsia in the community: a follow-up study. Br J Clin Pract. 1992;46:95–97.
Knill-Jones RP. Geographical differences in the prevalence of dyspepsia. Scand J Gastroenterol. 1991;26:17–24.
Jones RH, Lydeard SE, Hobbs FRD et al. Dyspepsia in England and Scotland. Gut. 1999;31:401–405.
Agreus L, Talley N. Challenges in managing dyspepsia in general practice. Br Med J. 1997;315:1284–1288.
Talley NJ. Modern management of dyspepsia. Aust Fam Phys. 1996;25:47–52.
Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer. 1997;33:1075–1107.
Tytgat G, Hingin APS, Malfertheiner P et al. Decision-making in dyspepsia: controversies in primary and secondary care. Eur J Gastroenterol Hepatol. 1999;11:223–230.
Sobala GM. Possible clinical uses of serology of Helicobacter pylori. In: Malfertheiner P, Ditschuneit H, editors. Helicobacter pylori, Gastritis and Peptic Ulcer. Berlin: Springer Verlag; 1990:147–153.
European Helicobacter pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut. 1997;41:8–13.
Malfertheiner P. The Maastricht recommendations and their impact on general practice. Eur J Gastroenterol Hepatol. 1999;11,2:63–67.
Sonnenberg A. Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects. Am J Gastroenterol. 1996;91:1773–1777.
Blum AL, Talley NJ, O’Morain C et al. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus clarithromycin and amoxicillin effect one year after treatment. (OCAY) Study Group. N Engl J Med. 1998;24,339,26:1875–1881.
McColl K, Murray L, El-Omar E et al Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med. 1998;24,339,26:1869–1874.
Talley NJ, Vakil N, Ballard ED, Fennerty MB. Absence of benefit of eradicating H. pylori in patients with nonulcer dyspepsia. N Engl J Med. 1999;7,341:1106–1111.
Megraud F, Doermann HP. Clinical relevance of resistant strains: a review of current data. Gut. 1998;43:S61–5.
Silverstein MD, Petterson T, Talley NJ. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology. 1996;110:72–83.
Ofman JJ, Etchason J, Fullerton S et al. Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences. Ann Intern Med. 1997;126:280–291.
Lim AG, Martin RM, Monteleone M et al. Helicobacter pylori serology and the management of young dyspeptics: a UK survey of gastroenterologists and general practitioners with an interest in gastroenterology. Aliment Pharmacol Ther. 1997;11:299–303.
Logan RP. Urea breath tests in the management of Helicobacter pylori infection. Gut. 1998;41,1:S47–50.
Leodolter A, Domingues-Munoz JE, von Arnim U, Kahl S, Peitz U, Malfertheiner P. Validity of a modified 13C-urea breath test for pre-and posttreatment diagnosis of Helicobacter pylori infection in the routine clinical setting. Am J Gastroenterol. 1999;94,8:2100–2104.
Thijs JC, van Zwet AA, Thijs WJ et al. Diagnostic tests for Helicobacter pylori: a prospective evaluation of their accuracy, without selecting a single test as the gold standard. Am J Gastroenterol. 1996;91,10:2125–2129.
Cohen H, Rose S, Lewin DN et al. Accuracy of four commercially available serologic tests, including two office-based tests and a commercially available 13C urea breath test, for diagnosis of Helicobacter pylori. Helicobacter. 1999;4,1:49–53.
Vaira D, Malfertheiner P, Megraud F et al. Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. Lancet. 1999;354:30–33.
Lassen AT, Pedersen FM, Byther P, Schaffalitzky de Muckadell OB. H. pylori ‘test and treat’ or prompt endoscopy for dyspeptic patients in primary care. A randomized controlled trial of two management strategies: one year follow up. Gastroenterology. 1998;114:G0803.
Heaney A, Collins JSA, Watson RGP, McFarland RJ, Bamford KB, Tham TCK. A prospective randomised trial of a ‘test and treat’ policy versus endoscopy based management in young Helicobacter pylori positive patients with ulcer-like dyspepsia, referred to a hospital clinic. Gut. 1999;45:186–190.
Besherdas K, Oben JA, Beck ER, Vicary FR, Wong VS. What proportion of dyspeptic patients having H. pylori breath test subsequently undergo endoscopy? Gut. 2000;46,2:W78.
Moayyedi P, Zilles A, Clough A, Hemingbrough E, Chlamers DM, Axon ATR. The effectiveness of screening and treating Helicobacter pylori in the management of dyspepsia. Eur J Gastroenterol Hepatol. 1999;11:1245–1250.
Joosen EAM, Reininga JHA, Manders JMW, ten Ham JC, de Boer WA. Costs and benefits of a test-and-treat strategy in Helicobacter pylori-infected subjects: a prospective intervention study in general practice. Eur J Gastroenterol Hepatol. 2000;12:319–325.
Christie J, Shepherd NA, Codling BW, Valori RM. Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia. Gut. 1997;41:513–517.
Gillen D, McColl KEL. Does concern about missing malignancy justify endoscopy in uncomplicated dyspepsia in patients aged less than 55? Am J Gastroenterol. 1999;94:75–79.